This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Evans, R. Articles by Eidlen, D. M. Search for Related Content PubMed PubMed Citation Articles by Evans, R. Articles by Eidlen, D. M.

Cyclophosphamide-induced Changes in the Cellular Composition of a Methylcholanthrene-induced Tumor and Their Relation to Bone Marrow and Blood Leukocyte Levels¹

The Jackson Laboratory, Bar Harbor, Maine 04609

A single i.p. injection of cyclophosphamide (CY) (6 mg) induced regression of a methylcholanthrene-induced fibrosarcoma (MCA/76-9) frequently to a nonpalpable mass. The extent of regression was dependent on dose of drug and time of administration in relation to tumor size, but even under optimal conditions few (<2%) permanent regressions were recorded. Well-marked histological changes were observed after CY injection, involving an initial increase in macrophage numbers followed by an accumulation of mature and immature granulocytes. These cells largely replaced neoplastic cells by 7 to 10 days after CY injection. Changes observed histologically were verified and quantitated after enzymic disaggregation of tumors at various times before and after CY injection. A bioassay was used to assess the number of tumorigenic cells associated with the tumor mass after CY injection by injecting graded doses of cells from enzymically disaggregated tumors into normal recipients. Within 1 hr after CY injection, more than 10⁶ tumor cells were required for a take (compared with 10² cells from control tumors). However, by 3 days fewer cells (10⁴) were required, and by 10 days only 10² cells were needed. Bone marrow and peripheral blood leukocyte numbers decreased rapidly after CY injection, but absolute numbers returned to control values by 7 to 10 days. However, differential counts on blood smears indicated that lymphocyte counts required at least 21 days to return to control values, whereas the number of monocytes and granulocytes was elevated above those of control mice by Days 7 to 10. The possibility is discussed that the observed intratumor cellular changes might reflect a variety of different reactions unrelated to tumor regression or recurrence.

¹ This research was supported by NIH Grant CA 20920.

² To whom requests for reprints should be addressed.

Received 6/ 6/79. Accepted 11/ 6/79.

This article has been cited by other articles:

				A. I. Chapoval, J. A. Fuller, S. G. Kremlev, S. J. Kamdar, and R. Evans Combination Chemotherapy and IL-15 Administration Induce Permanent Tumor Regression in a Mouse Lung Tumor Model: NK and T Cell-Mediated Effects Antagonized by B Cells J. Immunol., December 15, 1998; 161(12): 6977 - 6984. [Abstract] [Full Text] [PDF]